Issue 24, 2022

Hypochlorous acid-activated two-photon fluorescent probe for evaluation of anticancer drug-induced cardiotoxicity and screening of antioxidant drugs

Abstract

While the widespread use of chemotherapy has greatly improved the survival rates of cancer patients, this has been accompanied by immense suffering derived from significant toxic side effects. Since the cardiotoxicity caused by anticancer drugs seriously affects the prognosis and life quality of cancer patients, it is crucial to monitor the early stage of cardiotoxicity and myocardial damage induced by chemotherapy drugs in a timely manner. However, the traditional diagnostic methods have several disadvantages, including lack of specificity and delayed detection. Herein we developed a lysosomal targeted two-photon fluorescent probe (THPIC) for the real-time tracking of endogenous HClO specifically. THPIC has been employed as an imaging and diagnostic tool to verify that the administration of different anticancer drugs could lead to the elevation of HClO at varying degrees in H9C2 cells and the corresponding heart tissue sections, which would be prevented by the pre-treatment of conventional antioxidant drugs. Moreover, the results of H&E staining and western blot assay showed that the up-regulated HClO induced the activation of TNF-α through oxidative stress and then caused cardiotoxicity and myocardial injury. Antioxidant drugs canprotect the heart by depleting elevated ROS to maintain a normal redox balance in H9C2 cells. Therefore, HClO can be regarded as a biomarker for evaluating cardiotoxicity induced by anticancer drugs, and THPIC can be applied as a platform for screening drugs to prevent cardiotoxicity.

Graphical abstract: Hypochlorous acid-activated two-photon fluorescent probe for evaluation of anticancer drug-induced cardiotoxicity and screening of antioxidant drugs

Supplementary files

Article information

Article type
Research Article
Submitted
04 Sep 2022
Accepted
03 Oct 2022
First published
04 Oct 2022

Org. Chem. Front., 2022,9, 6795-6801

Hypochlorous acid-activated two-photon fluorescent probe for evaluation of anticancer drug-induced cardiotoxicity and screening of antioxidant drugs

K. Liu, J. Zhang, X. Li, Y. Xie, Y. Li, X. Wang, X. Jiao, X. Xie and B. Tang, Org. Chem. Front., 2022, 9, 6795 DOI: 10.1039/D2QO01408D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements